Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors
A Chauhan, K Chan, TR Halfdanarson… - CA: a cancer journal …, 2024 - Wiley Online Library
Abstract The American Joint Committee on Cancer (AJCC) staging system for all cancer
sites, including gastroenteropancreatic neuroendocrine tumors (GEP‐NETs), is meant to be …
sites, including gastroenteropancreatic neuroendocrine tumors (GEP‐NETs), is meant to be …
[HTML][HTML] Somatostatin receptor PET ligands-the next generation for clinical practice
Somatostatin receptors (SSTRs) are variably expressed by a variety of malignancies. Using
radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on tumor cells may be …
radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on tumor cells may be …
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
B Kos‐Kudła, JP Castaño, T Denecke… - Journal of …, 2023 - Wiley Online Library
This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …
neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working …
[PDF][PDF] SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors
Somatostatin receptor (SSTR) imaging using PET has replaced scintigraphic imaging using
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …
[HTML][HTML] 2020 FDA TIDES (peptides and oligonucleotides) harvest
2020 has been an extremely difficult and challenging year as a result of the coronavirus
disease 2019 (COVID-19) pandemic and one in which most efforts have been channeled …
disease 2019 (COVID-19) pandemic and one in which most efforts have been channeled …
[HTML][HTML] Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs
Theranostics is an emerging paradigm that combines imaging and therapy in order to
personalize patient treatment. In nuclear medicine, this is achieved by using …
personalize patient treatment. In nuclear medicine, this is achieved by using …
[HTML][HTML] Overview of radiolabeled somatostatin analogs for cancer imaging and therapy
R Eychenne, C Bouvry, M Bourgeois, P Loyer… - Molecules, 2020 - mdpi.com
Identified in 1973, somatostatin (SST) is a cyclic hormone peptide with a short biological half-
life. Somatostatin receptors (SSTRs) are widely expressed in the whole body, with five …
life. Somatostatin receptors (SSTRs) are widely expressed in the whole body, with five …
Role of biomarker tests for diagnosis of neuroendocrine tumours
Neuroendocrine tumours (NETs) are neoplasms that arise from neuroendocrine cells.
Neuroendocrine cells and their tumours can secrete a wide range of amines and …
Neuroendocrine cells and their tumours can secrete a wide range of amines and …
Recent advances in radiometals for combined imaging and therapy in cancer
N Herrero Álvarez, D Bauer, J Hernández‐Gil… - …, 2021 - Wiley Online Library
Nuclear medicine is defined as the use of radionuclides for diagnostic and therapeutic
applications. The imaging modalities positron emission tomography (PET) and single …
applications. The imaging modalities positron emission tomography (PET) and single …
[HTML][HTML] Update on epidemiology, diagnosis, and biomarkers in gastroenteropancreatic neuroendocrine neoplasms
D Takayanagi, H Cho, E Machida, A Kawamura… - Cancers, 2022 - mdpi.com
Simple Summary Neuroendocrine neoplasms are divided into two groups: well-
differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas …
differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas …